News Listing

Filter by
Date
Sep 08, 2017 02:07 PM

Genetic profiling: the cancer game-changer

Across Australia, new initiatives seek to treat patients on the basis of their tumour's genetic information. This article was written by Jamie Walker and originally appeared in The Weekend Australian on August 26, 2017.

MEDIA RELEASE: Sep 07, 2017 10:48 PM

‘Partner in crime’ mutations work together to kickstart lymp...

Australian researchers have uncovered ‘extraordinary cooperation’ between two DNA mutations that are often found together in lymphomas and leukaemias. The findings help us understand how immune cells can ‘go rogue’, beha...

Sep 06, 2017 10:50 AM

Osteoporosis: major study identifies 150 new genetic sites t...

In the largest ever study of its kind, an international research team has identified over 150 new sites in the human genome that are linked to low bone mineral density and to an increased risk of fracture. The findings v...

Aug 31, 2017 01:20 PM

Professor Mark Febbraio: exercise is medicine

Garvan congratulates Professor Mark Febbraio, who has won the 2017 Australian Diabetes Society (ADS) Kellion Award. The award recognises an Australian researcher who has made an outstanding contribution to diabetes resea...

Aug 23, 2017 09:49 PM

Top-flight researchers gather for inaugural immunometabolism...

Leading researchers from across the world gathered in Fiji this month to explore the intersection of immunology and metabolism, and to uncover how the new field of immunometabolism can shed light on chronic disease.

MEDIA RELEASE: Aug 23, 2017 06:00 AM

Ground-breaking trial brings personalised treatments to thos...

Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.

Aug 16, 2017 07:09 AM

Rare Cancers Australia sets new agenda for change

Garvan is proud to support Rare Solutions: A Time to Act, a new report released by Rare Cancers Australia that sets out a roadmap for change in the treatment and care of patients with rare cancer in Australia.

MEDIA RELEASE: Aug 04, 2017 01:00 AM

Top-to-toe MRI screen picks up early-stage cancers while sti...

A major study shows that whole-body MRI screening can identify previously undetected primary tumours throughout the body in people with high genetic risk of cancer.

MEDIA RELEASE: Aug 03, 2017 09:55 PM

New single-cell tech to accelerate disease understanding

Together with the Weizmann Institute of Science, Garvan has officially opened the Garvan-Weizmann Centre for Cellular Genomics, the first of its kind in Australia.

Jul 28, 2017 06:32 AM

Done in 180 seconds: snappy science from Precinct PhD studen...

Eight PhD students entertained and informed their audience at the 2017 St Vincent’s Precinct Three Minute Thesis competition, held this week at Garvan.

Jul 27, 2017 03:29 PM

Garvan reaches 15,000 genomes

Garvan has now sequenced more than 15,000 whole genomes, a major milestone for the Kinghorn Centre for Clinical Genomics (KCCG) and Garvan’s wholly owned subsidiary, Genome.One.

Jul 26, 2017 01:43 PM

Spanning research and the clinic: top diabetes awards for Ga...

Three prestigious awards from the Australian Diabetes Society commend the outstanding achievements of Professors Mark Febbraio, Jerry Greenfield and Don Chisholm.

Jul 17, 2017 11:13 AM

John Mattick: Let’s invest in the scientists looking over ou...

In this opinion piece in The Australian, Garvan's Executive Director, Professor John Mattick AO FAA says Australia needs to invest in farsighted and trailblazing researchers.

Jul 14, 2017 11:30 AM

Immunotherapy – changing the way we think about cancer treat...

Garvan scientists are looking beyond their specialty areas and taking an inter-disciplinary approach that is changing the way we think about the treatment of cancer.

MEDIA RELEASE: Jul 14, 2017 04:00 AM

We inherit more than DNA: the extra blueprint layer we can’t...

An international study has provided compelling evidence that we inherit more than a DNA blueprint from our mothers and fathers – we also inherit vital instructions on how to use that blueprint.

Jul 07, 2017 11:40 AM

Genomics at Garvan and Genome.One highlighted on ABC

This week’s episode of ‘Ask the Doctor’ – which explored the role of genomics in medicine – focused on the work of Garvan and its wholly owned subsidiary Genome.One.

Jul 07, 2017 11:10 AM

Interleukin-2: releasing an immune system brake to attack tu...

Researchers from Garvan’s Immunology Division have been exploring ways to make interleukin-2 immunotherapy less toxic and more effective against cancer. In doing so, the team has uncovered surprising new information abou...

MEDIA RELEASE: Jun 30, 2017 05:00 AM

Promising new therapeutic approach rebuilds and strengthens ...

Garvan researchers demonstrate that a new therapeutic approach increases bone strength and resistance to fractures in multiple myeloma bone disease

Jun 29, 2017 11:01 AM

Supporting a new mentoring program for women in health and m...

Garvan researchers are taking part – both as mentees and mentors – in a new mentoring program for women in health and medical research, launched on Thursday (June 22nd) by Franklin Women.

Jun 27, 2017 02:51 PM

Success for Garvan researchers at key bone biology conferenc...

Garvan congratulates Bone Biology Division researchers Dr Michelle McDonald, Scott Youlten, Thao Ho-Le and Dr Weiwen Chen, all of whom received awards at last week’s ANZBMS-IFMRS conference.

MEDIA RELEASE: Jun 20, 2017 12:00 AM

Genome.One news: Australia’s first whole genome and health ...

Genome.One has today launched Australia's first clinical service that combines whole genome sequencing with a comprehensive health assessment to enable a more precise approach to managing health.